share_log

醫渡科技：自願性公告- 於市場購回股份

YIDU TECH: VOLUNTARY ANNOUNCEMENT - ON-MARKET SHARE REPURCHASE

香港交易所 ·  Feb 28 17:11
Summary by Moomoo AI
醫渡科技有限公司（「本公司」）宣佈，根據2023年9月28日股東週年大會授予的股份購回授權，計劃在市場條件適宜時購回最多105,285,814股普通股，即不超過股份總數的10%。董事會表示，此舉旨在保護投資者權益，增強投資者信心，並反映了對公司未來發展前景的信心。購回將使用公司的內部現金資源，且不會影響公司營運資金。董事會認為，建議股份購回符合公司及股東的整體利益。截至2024年2月29日公告日期，尚未進行任何股份購回，具體購回的時間、數量或價格將由董事會根據市場情況決定。
醫渡科技有限公司（「本公司」）宣佈，根據2023年9月28日股東週年大會授予的股份購回授權，計劃在市場條件適宜時購回最多105,285,814股普通股，即不超過股份總數的10%。董事會表示，此舉旨在保護投資者權益，增強投資者信心，並反映了對公司未來發展前景的信心。購回將使用公司的內部現金資源，且不會影響公司營運資金。董事會認為，建議股份購回符合公司及股東的整體利益。截至2024年2月29日公告日期，尚未進行任何股份購回，具體購回的時間、數量或價格將由董事會根據市場情況決定。
Medical Technology Co., Ltd. (the “Company”) announces that pursuant to the share repurchase authorization granted at the Annual General Meeting on September 28, 2023, it plans to repurchase a maximum of 105,285,814 shares of ordinary shares, not exceeding 10% of the total number of shares, when market conditions are right. The Board of Directors said the move was designed to protect investor interests, enhance investor confidence and reflect confidence in the future prospects of the company. The buyback will use the company's internal cash resources and will not affect the company's working capital. The Board considers that the proposed share repurchase is in the overall interests of the Company and its shareholders. As of the announcement date of 29 February 2024, no share repurchases have been made and the specific timing, quantity or price of the repurchases will be determined by the Board of Directors based on market conditions.
Medical Technology Co., Ltd. (the “Company”) announces that pursuant to the share repurchase authorization granted at the Annual General Meeting on September 28, 2023, it plans to repurchase a maximum of 105,285,814 shares of ordinary shares, not exceeding 10% of the total number of shares, when market conditions are right. The Board of Directors said the move was designed to protect investor interests, enhance investor confidence and reflect confidence in the future prospects of the company. The buyback will use the company's internal cash resources and will not affect the company's working capital. The Board considers that the proposed share repurchase is in the overall interests of the Company and its shareholders. As of the announcement date of 29 February 2024, no share repurchases have been made and the specific timing, quantity or price of the repurchases will be determined by the Board of Directors based on market conditions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more